Cite

HARVARD Citation

    Ahmed, A. et al. (2017). Treatment of patients waitlisted for liver transplant with all‐oral direct‐acting antivirals is a cost‐effective treatment strategy in the United States. Hepatology. 66 (1), pp. 46-56. [Online]. 
  
Back to record